FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 93 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $72,464,000 | +237.2% | 3,632,271 | +16.5% | 0.00% | +100.0% |
| Q2 2022 | $21,489,000 | -23.4% | 3,119,060 | +3.3% | 0.00% | 0.0% |
| Q1 2022 | $28,069,000 | -34.8% | 3,018,285 | -0.3% | 0.00% | 0.0% |
| Q4 2021 | $43,039,000 | -45.6% | 3,026,666 | -11.2% | 0.00% | -50.0% |
| Q3 2021 | $79,070,000 | -4.7% | 3,409,686 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $82,986,000 | -10.0% | 3,334,125 | +1.4% | 0.00% | -33.3% |
| Q1 2021 | $92,176,000 | +0.2% | 3,289,576 | +24.9% | 0.00% | 0.0% |
| Q4 2020 | $91,952,000 | +26.6% | 2,634,750 | +80.7% | 0.00% | 0.0% |
| Q3 2020 | $72,655,000 | +179.2% | 1,457,768 | +160.4% | 0.00% | +200.0% |
| Q2 2020 | $26,027,000 | – | 559,852 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |